Paul Tudor Jones's WST Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 40,670 shares of West Pharmaceutical Services, Inc. (WST) worth $11.19 M, representing 0.02% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 34 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in WST, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2023, adding 47,477 shares. Largest reduction occurred in Q1 2024, reducing 54,293 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's West Pharmaceutical Services (WST) Holding Value Over Time
Track share changes against reported price movement
Quarterly West Pharmaceutical Services (WST) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +40,670 | New Buy | 40,670 | $275.14 |
| Q3 2025 | -12,508 | Sold Out | 0 | $0.00 |
| Q2 2025 | +12,508 | New Buy | 12,508 | $218.80 |
| Q1 2024 | -54,293 | Sold Out | 0 | $0.00 |
| Q4 2023 | -512 | Reduce 0.93% | 54,293 | $352.12 |
| Q3 2023 | +7,328 | Add 15.43% | 54,805 | $375.21 |
| Q2 2023 | +47,477 | New Buy | 47,477 | $382.47 |
| Q1 2023 | -19,228 | Sold Out | 0 | $0.00 |
| Q4 2022 | -462 | Reduce 2.35% | 19,228 | $0.24 |
| Q3 2022 | +14,865 | Add 308.08% | 19,690 | $246.06 |
| Q2 2022 | +4,825 | New Buy | 4,825 | $302.38 |
| Q1 2022 | -975 | Sold Out | 0 | $0.00 |
| Q4 2021 | +975 | New Buy | 975 | $468.72 |
| Q3 2021 | -2,381 | Sold Out | 0 | $0.00 |
| Q2 2021 | -733 | Reduce 23.54% | 2,381 | $359.09 |
| Q1 2021 | +689 | Add 28.41% | 3,114 | $281.63 |
| Q4 2020 | -2,692 | Reduce 52.61% | 2,425 | $283.30 |
| Q3 2020 | +5,117 | New Buy | 5,117 | $274.97 |
| Q2 2020 | -2,154 | Sold Out | 0 | $0.00 |
| Q1 2020 | +2,154 | New Buy | 2,154 | $152.27 |
| Q4 2019 | -11,528 | Sold Out | 0 | $0.00 |
| Q3 2019 | +11,528 | New Buy | 11,528 | $141.83 |
| Q4 2016 | -12,557 | Sold Out | 0 | $0.00 |
| Q3 2016 | -1,443 | Reduce 10.31% | 12,557 | $74.46 |
| Q2 2016 | +9,600 | Add 218.18% | 14,000 | $75.86 |
| Q1 2016 | +4,400 | New Buy | 4,400 | $69.32 |
| Q1 2015 | -3,800 | Sold Out | 0 | $0.00 |
| Q4 2014 | -7,797 | Reduce 67.23% | 3,800 | $53.16 |
| Q3 2014 | -15,113 | Reduce 56.58% | 11,597 | $44.75 |
| Q2 2014 | +13,993 | Add 110.03% | 26,710 | $42.19 |
| Q1 2014 | +5,717 | Add 81.67% | 12,717 | $44.04 |
| Q4 2013 | -300 | Reduce 4.11% | 7,000 | $49.00 |
| Q3 2013 | -1,900 | Reduce 20.65% | 7,300 | $41.10 |
| Q2 2013 | +9,200 | Add 0.00% | 9,200 | $35.11 |
Paul Tudor Jones's West Pharmaceutical Services Investment FAQs
Paul Tudor Jones first purchased West Pharmaceutical Services, Inc. (WST) in Q2 2013, acquiring 9,200 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held West Pharmaceutical Services, Inc. (WST) for 34 quarters since Q2 2013.
Paul Tudor Jones's largest addition to West Pharmaceutical Services, Inc. (WST) was in Q2 2023, adding 47,477 shares worth $18.16 M.
According to the latest 13F filing for Q4 2025, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 40,670 shares of West Pharmaceutical Services, Inc. (WST), valued at approximately $11.19 M.
As of the Q4 2025 filing, West Pharmaceutical Services, Inc. (WST) represents approximately 0.02% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in West Pharmaceutical Services, Inc. (WST) was 54,805 shares, as reported at the end of Q3 2023.